f-chemotactic peptide has been researched along with lignans in 1 studies
| Studies (f-chemotactic peptide) | Trials (f-chemotactic peptide) | Recent Studies (post-2010) (f-chemotactic peptide) | Studies (lignans) | Trials (lignans) | Recent Studies (post-2010) (lignans) |
|---|---|---|---|---|---|
| 79 | 0 | 4 | 7,024 | 95 | 4,172 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SH; Fang, JY; Hwang, TL; Lee, YT; Lin, CF; Liu, FC; Syu, YT; Yu, HP | 1 |
1 other study(ies) available for f-chemotactic peptide and lignans
| Article | Year |
|---|---|
Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Brain; Cell Adhesion; Coculture Techniques; Endothelial Cells; Gene Expression Regulation; HEK293 Cells; Humans; Lignans; Magnolia; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophil Activation; Neutrophils; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Receptors, Formyl Peptide; Receptors, Lipoxin; THP-1 Cells | 2017 |